TTM
$25.48B
YoY change
+15.6%
5Y CAGR
+5.3%
Peak year (2025)
$25.60B
Cumulative operating income
$498.83B
Operating Income history chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: $25.60B
Operating Income growth chart for Johnson & Johnson (JNJ) from 1985 to 2025
Latest: +15.6%
Operating Income history table for Johnson & Johnson (JNJ) from 1985 to 2025
| 2025 | $25.60B | +15.6% | +$3.45B | ||
| 2024 | $22.15B | -5.4% | −$1.26B | ||
| 2023 | $23.41B | +11.4% | +$2.40B | ||
| 2022 | $21.01B | +0.3% | +$70.00M | ||
| 2021 | $20.94B | +6.1% | +$1.21B | ||
| 2020 | $19.73B | -5.9% | −$1.24B | ||
| 2019 | $20.97B | -1.0% | −$205.00M | ||
| 2018 | $21.18B | +12.1% | +$2.28B | ||
| 2017 | $18.90B | -9.5% | −$1.99B | ||
| 2016 | $20.89B | +14.2% | +$2.60B | ||
| 2015 | $18.29B | -13.5% | −$2.85B | ||
| 2014 | $21.14B | +11.5% | +$2.18B | ||
| 2013 | $18.96B | +11.3% | +$1.93B | ||
| 2012 | $17.03B | +5.4% | +$879.00M | ||
| 2011 | $16.15B | -2.3% | −$374.00M | ||
| 2010 | $16.53B | -0.8% | −$136.00M | ||
| 2009 | $16.66B | +3.1% | +$494.00M | ||
| 2008 | $16.17B | +6.3% | +$956.00M | ||
| 2007 | $15.21B | +11.0% | +$1.50B | ||
| 2006 | $13.71B | +6.8% | +$878.00M | ||
| 2005 | $12.83B | +3.8% | +$475.00M | ||
| 2004 | $12.36B | +13.7% | +$1.49B | ||
| 2003 | $10.87B | +12.3% | +$1.19B | ||
| 2002 | $9.68B | +22.7% | +$1.79B | ||
| 2001 | $7.88B | +19.2% | +$1.27B | ||
| 2000 | $6.62B | +10.5% | +$630.00M | ||
| 1999 | $5.99B | +19.0% | +$957.00M | ||
| 1998 | $5.03B | +8.8% | +$406.00M | ||
| 1997 | $4.62B | +7.4% | +$319.00M | ||
| 1996 | $4.30B | +22.6% | +$792.00M | ||
| 1995 | $3.51B | +25.1% | +$704.00M | ||
| 1994 | $2.81B | +17.3% | +$413.00M | ||
| 1993 | $2.39B | +5.1% | +$117.00M | ||
| 1992 | $2.28B | +5.2% | +$113.00M | ||
| 1991 | $2.16B | +8.6% | +$172.00M | ||
| 1990 | $1.99B | +19.9% | +$331.00M | ||
| 1989 | $1.66B | +18.3% | +$257.00M | ||
| 1988 | $1.40B | +16.1% | +$195.00M | ||
| 1987 | $1.21B | +22.9% | +$225.40M | ||
| 1986 | $983.60M | +17.1% | +$143.60M | ||
| 1985 | $840.00M | — | — |
- 2025$25.60B+15.6%
- 2024$22.15B-5.4%
- 2023$23.41B+11.4%
- 2022$21.01B+0.3%
- 2021$20.94B+6.1%
- 2020$19.73B-5.9%
- 2019$20.97B-1.0%
- 2018$21.18B+12.1%
- 2017$18.90B-9.5%
- 2016$20.89B+14.2%
- 2015$18.29B-13.5%
- 2014$21.14B+11.5%
- 2013$18.96B+11.3%
- 2012$17.03B+5.4%
- 2011$16.15B-2.3%
- 2010$16.53B-0.8%
- 2009$16.66B+3.1%
- 2008$16.17B+6.3%
- 2007$15.21B+11.0%
- 2006$13.71B+6.8%
- 2005$12.83B+3.8%
- 2004$12.36B+13.7%
- 2003$10.87B+12.3%
- 2002$9.68B+22.7%
- 2001$7.88B+19.2%
- 2000$6.62B+10.5%
- 1999$5.99B+19.0%
- 1998$5.03B+8.8%
- 1997$4.62B+7.4%
- 1996$4.30B+22.6%
- 1995$3.51B+25.1%
- 1994$2.81B+17.3%
- 1993$2.39B+5.1%
- 1992$2.28B+5.2%
- 1991$2.16B+8.6%
- 1990$1.99B+19.9%
- 1989$1.66B+18.3%
- 1988$1.40B+16.1%
- 1987$1.21B+22.9%
- 1986$983.60M+17.1%
- 1985$840.00M—
Operating Income values are taken from Johnson & Johnson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Operating Income at Johnson & Johnson (JNJ)
According to Johnson & Johnson's latest reported financial statements, the company's current operating income (TTM) is $25.48B. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2025, Johnson & Johnson (JNJ) operating income totalled $25.60B – grew 15.6% year-over-year.
Johnson & Johnson operating income has grown on net over the period, with a +5.3% compound annual growth rate over 2020–2025 (5 years).
The record annual operating income stands at $25.60B, reached in 2025; the historical low of $840.00M was recorded in 1985.
Johnson & Johnson Operating Income by Year
Johnson & Johnson Operating Income 2025: $25.60B
Johnson & Johnson posted operating income of $25.60B in 2025, grew 15.6% from 2024. This figure represents the highest annual value in the available history.
Johnson & Johnson Operating Income 2024: $22.15B
In 2024, Johnson & Johnson reported operating income of $22.15B, declined 5.4% below 2023.
Johnson & Johnson Operating Income 2023: $23.41B
Johnson & Johnson operating income in 2023 was $23.41B, grew 11.4% from 2022.
Johnson & Johnson Operating Income 2022: $21.01B
2022's operating income for Johnson & Johnson came in at $21.01B, edged up 0.3% from 2021.
Johnson & Johnson Operating Income 2021: $20.94B
Johnson & Johnson operating income in 2021 was $20.94B.
See more financial history for Johnson & Johnson (JNJ).
Sector peers by Operating Income
Healthcare peers of Johnson & Johnson (JNJ), ranked by their latest operating income
| $29.70B | |
| $23.49B | |
| $20.09B | |
| $19.90B | |
| $18.96B | |
| $13.74B | |
| $10.68B | |
| $8.11B |
- $29.70B
- $23.49B
- $20.09B
- $19.90B
- $18.96B
- $13.74B
- $10.68B
Frequently asked questions
Johnson & Johnson (JNJ) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation